Authors: Asselin-Paturel, C Lassau, N Guinebretiere, JM Zhang, J Gay, F Bex, F Hallez, S Leclere, J Peronneau, P Mami-Chouaib, F Chouaib, S

Citation: C. Asselin-paturel et al., Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography, GENE THER, 6(4), 1999, pp. 606-615

Authors: Le Buanec, H D'Anna, R Lachgar, A Zagury, JF Bernard, J Ittele, D d'Alessio, P Hallez, S Giannouli, C Burny, A Bizzini, B Gallo, RC Zagury, D

Citation: H. Le Buanec et al., HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes, BIOMED PHAR, 53(9), 1999, pp. 424-431

Authors: Le Buanec, H Lachgar, A D'Anna, R Zagury, JF Bizzini, B Bernard, J Ittele, D Hallez, S Giannouli, C Burny, A Zagury, D

Citation: H. Le Buanec et al., Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein, BIOMED PHAR, 53(7), 1999, pp. 323-328

Authors: Hallez, S Detremmerie, O Giannouli, C Thielemans, K Gajewski, TF Burny, A Leo, O

Citation: S. Hallez et al., Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity, INT J CANC, 81(3), 1999, pp. 428-437